[
    [
        {
            "time": "2018-01-02",
            "original_text": "Zacks.com highlights: Jones Lang LaSalle, Intel, Dollar General, AbbVie and Owens Corning",
            "features": {
                "keywords": [
                    "Jones Lang LaSalle",
                    "Intel",
                    "Dollar General",
                    "AbbVie",
                    "Owens Corning"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "real estate",
                    "technology",
                    "retail",
                    "pharmaceuticals",
                    "materials"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Zacks.com highlights: Jones Lang LaSalle, Intel, Dollar General, AbbVie and Owens Corning",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "Better Buy: Eli Lilly and Company vs. Johnson & Johnson",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Johnson & Johnson",
                    "Better Buy"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Better Buy: Eli Lilly and Company vs. Johnson & Johnson",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "Bristol-Myers Squibb’s Virology Products in 4Q17",
            "features": {
                "keywords": [
                    "Bristol-Myers Squibb",
                    "Virology Products",
                    "4Q17"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Bristol-Myers Squibb’s Virology Products in 4Q17",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        }
    ]
]